Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$3.85 - $6.59 $57,850 - $99,021
15,026 New
15,026 $59,000
Q3 2023

May 09, 2024

BUY
$4.8 - $6.4 $71,654 - $95,539
14,928 New
14,928 $75,000
Q2 2023

Apr 29, 2024

BUY
$5.03 - $9.9 $75,087 - $147,787
14,928 New
14,928 $75,000
Q2 2023

Aug 10, 2023

BUY
$5.03 - $9.9 $75,087 - $147,787
14,928 New
14,928 $75,000

Others Institutions Holding PDSB

About PDS Biotechnology Corp


  • Ticker PDSB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,458,700
  • Market Cap $38.1M
  • Description
  • PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...
More about PDSB
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.